This webinar will focus on the challenges facing ethnic and racial minorities, impoverished people and sexual and gender minorities (LGBTQ) and options available to clinicians to improve these patients access to comprehensive biomarker testing and precision medicines.
Genomic Testing Cooperative's Reducing Cancer Disparity Program provides comprehensive genomic profiling of DNA and RNA to patients with both solid tumors and hematologic neoplasms free of charge. The testing will provide the treating physician and patient with a proper diagnosis, all relevant biomarkers, classification of the tumor, help in determining prognosis, selecting therapy and in developing a strategy for treatment that is specific for the patient. Patients must be nominated for this program by their physicians.
Maher Albitar, MD
Chief Executive Officer; Chief Medical Officer
Genomic Testing Cooperative
Martin Gutierrez, MD
Chief, Thoracic Oncology; Director, Drug Discovery
Hackensack Meridian Health
Director, Precision Medicine Initiatives
This webinar is sponsored by the Genomic Testing Cooperative.